A comparative study of perioperative outcomes and pain management after laparoscopic vs. vaginal approach for genital prolapse repair

2021 ◽  
Vol 79 ◽  
pp. S544
Author(s):  
T. Taha ◽  
B. Taha ◽  
M. Ben Zvi ◽  
A. Ben Zvi ◽  
A. Ben Zvi
Author(s):  
OJS Admin

Ketoprofen belongs to non-steroidal anti-inflammatory drug which has better results in pain management with combination of steroid and anesthetic drug. In this study compression of two combination had been observed.


Author(s):  
Nalini K ◽  
Suresh M ◽  
Deepak P ◽  
Raghu N ◽  
Sahana N ◽  
...  

2010 ◽  
Vol 1 (3) ◽  
pp. 32-37
Author(s):  
S A Levakov ◽  
N S Wanke ◽  
O R Shablovskiy ◽  
A G Kedrova ◽  
V N Shirshov ◽  
...  

The aim was to evaluated anatomical and symptom specific outcome measures of prolapse repair with PROLIFT ® (Gynecare). In this longitudinal prospective observational study we collected data on a total of 85 women with pelvic organ prolapse stage 2 or more. Objective success rate was 85.9% at 6 months respectively. Patients required a blood more 500 ml - 7,1% and need transfusion. The mesh erosion rate or the displacement of the mesh were 3,5%. Vaginal surgery with prolift mesh® is an effective and safe procedure to correct pelvic organ prolapse over one year follow up.


1999 ◽  
Vol 18 (6) ◽  
pp. 591-598 ◽  
Author(s):  
Lindsey L. Cohen ◽  
Ronald L. Blount ◽  
Rachelle Jansevics Cohen ◽  
Elizabeth R. Schaen ◽  
Jon F. Zaff

2021 ◽  
Vol 17 (7) ◽  
pp. 171-177
Author(s):  
Ashley L. Sharp, MD ◽  
Stephanie Gilbert, MD ◽  
Danielle N. Perez, MD ◽  
Kerstin Kolodzie, MD, PhD, MAS ◽  
Matthias Behrends, MD

Objective: Pain management following spine surgery can be challenging as patients routinely suffer from chronic pain and opioid tolerance. The increasing popularity of buprenorphine use for pain management in this population may further complicate perioperative pain management due to the limited efficacy of other opioids in the presence of buprenorphine. This study describes perioperative management and outcomes in patients on chronic buprenorphine who underwent elective inpatient spine surgery.Design: The authors performed a retrospective chart review of all patients 18 years of age taking chronic buprenorphine for any indication who had elective inpatient spine surgery at a single institution. Perioperative pain management data were analyzed for all patients who underwent spine surgery and were maintained on buprenorphine during their hospital stay.Setting: The study was performed at a single tertiary academic medical center. Main outcome measures: The primary outcome measures were post-operative pain scores and analgesic medication requirements.Results: Twelve patients on buprenorphine underwent inpatient spine surgery. Acceptable pain control was achieved in all cases. Management included preoperative dose limitation of buprenorphine when indicated and the extensive use of multimodal analgesia.Conclusion: The question whether patients presenting for painful, elective surgery should continue using buprenorphine perioperatively is an area of controversy, and the present manuscript provides more evidence for the concept of therapy continuation with buprenorphine.


Sign in / Sign up

Export Citation Format

Share Document